Abstract
Urticaria is conventionally classified as acute, intermittent or chronic (Greaves, 2000a). The cause of acute urticaria is often recognized by the patient if it is due to an IgE-mediated hypersensitive reaction, and will not be considered further. Intermittent urticaria — frequent bouts of unexplained urticaria at intervals of weeks or months — will be discussed here on the same basis as the ordinary presentation of chronic urticaria but may have a definable external trigger, such as food or drug intolerance. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks with or without angioedema. The etiology of chronic urticaria has conventionally been regarded as obscure and hence the term idiopathic is often applied. However, there is increasing evidence that up to 50% of patients with ‘idiopathic’ chronic urticaria have autoimmune chronic urticaria. The diagnosis is important since it carries conceptual, prognostic and therapeutic implications. Contact urticaria and angioedema without wheals will not be dealt with in this account.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adachi J, Aoki T, Yamatodani A (1994) Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci 7:142–149
Adams DD (1988) Long-acting thyroid stimulator: how receptor autoimmunity was discovered. J Autoimmunity 1:3–9
Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A (2001) Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 31:1105–1110
Bentley-Phillips CB, Black AK, Greaves MW (1976) Induced tolerance in cold urticaria caused by cold-evoked histamine release. Lancet ii:63–66
Black AK, Lawlor F, Greaves MW (1996) Consensus meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol 21:424–426
Black AK (2004) Physical and Cholinergic Urticarias. In: Urticaria and Angioedema. Eds Malcolm W Greaves, Allen P Kaplan. Marcel Dekker, New York, (2004) chapter 8, pp 171–214
Borzova E, Rutherford A, Konstatninou K, Leslie K, Grattan CEH (2008) Narrow-band ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism. J Am Acad Dermatol 59:752–757
Bunselmeyer B, Laubach HJ, Schiller M, Stanke M, Luger TA, Brehler R (2009) Incremental buildup food challenge — a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise food challenge in chronic Clin Exp Allergy 39:116–126
Burova GP, Mallet AI, Greaves MW (1998) Is Helicobacter pylori a cause of chronic urticaria? Br J Dermatol 139(Suppl):42
Caproni M, Volpi W, Macchia D, Giomi B, Manfredi M, Campi P, Cardinali C, D’Agata A, Fabbri P. (2003) Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test. Exp Dermatol 2:621–628
Commens CA, Greaves MW (1978) Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 98:47–51
Engler RJM, Squire E, Benson P (1995) Chronic sulphasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 74:155–159
Erbagci Z (2002) The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 110:484–848
Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M (2000) Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 106:567–572
Ferrer M, Kinet JP, Kaplan AP (1998) Comparative studies of functional and binding assays for IgG anti-FcεRIαh (α-subunit) in chronic urticaria. J Allergy Clin Immunol 101:672–676
Fiebiger E, Maurer D, Holubar H, Reininger B, Hartmann G, Woisetschlager M, Stingl G (1995) Serum IgG autoantibodies directed against the alpha chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients. J Clin Invest 96:2606–2612
Fiebiger E, Hammerschmid F, Stingl G, Maurer D (1998) Anti-FcεRIα autoantibodies in autoimmune-mediated disorders. J Clin Invest 101:243–261
Feinberg JH, Toner CB (2008) Successful treatment of disabling cholinergic urticaria. Mil Med 173:217–220
Fukunaga A, Bito T, Tsuru K, Oohashi A, Yu X, Ichihashi M, Nishigori C, Horikawa T (2005) Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 116:3970402
Fung-Leung W-P, Sousa-Hitzien JD, Ishaque A (1996) Transgenic mice expressing the human high affinity immunoglobulin (Ig)E receptor α chain, respond to human IgE in mast cell degranulation and allergic reactions. J Exp Med 183:49–56
Grattan CEH, Wallington TB, Warin RP (1986) A serological mediator in chronic idiopathic urticaria: a clinical immunological and histological evaluation. Br J Dermatol 114:583–590
Grattan CEH, Francis DM, Hide M, Greaves MW (1991) Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 21:695–704
Grattan CEH, Francis DM, Slater NGP, Greaves MW (1992) Plasmapheresis for severe unremitting chronic urticaria. Lancet 339:1078–1080
Grattan CEH, Francis DM (1999) Autoimmune urticaria. Advances Dermatol 15, 311–340
Grattan CEH, O’Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Black AK, Greaves MW (2000) Randomised double blind study of cyclosporin in chronic idiopathic urticaria. Br J Dermatol 143:365–372
Grattan CEH (2003) Aspirin sensitivity and urticaria. Clin Exp Dermatol 28:123–127
Grattan CEH, Humphreys F (2007) Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 157:1116–1123
Greaves MW (1995) Current concepts in chronic urticaria. New Eng J Med 332:1767–1772
Greaves MW (2000a) Management of urticaria. Hosp Med 61:463–469
Greaves MW (2000b) Chronic urticaria. J Allergy Clin Immunol 105:664–672
Greaves MW (2001) Chronic idiopathic urticaria (CIU) and Helicobacter pylori — not directly causative, but could there be a link? Allergy Clin Immunol Internat 13:23–26
Hayashi S Hashimoto S (1999) Anti-inflammatory actions of new antihistamines. Clin Exp Allergy 29:1593–1596
Henz BM, Zuberbier T (1998) Causes of urticaria. pp 20–38. in Urtcaria eds Henz BM, Zuberbier T, Grabbe J, Monroe E. Springer, Verlag Berlin Heidelberg
Herxheimer A (1956) The nervous pathway mediating cholinergic urticaria. Clin Sci 15:195–205
Hide M, Francis DM, Grattan CH, Greaves MW (1993) Autoantibodies against the high affinity IgE receptor as a cause for histamine release in chronic urticaria. New Eng J Med 328:1599–1604
Hide M, Francis DM, Grattan CEH, Barr RM, Winkelmann RK, Greaves MW (1994) The pathogenesis of chronic urticaria: new evidence suggests an autoimmune basis and implications for treatment. Clin Exp Allergy 24:624–627
Hide M, Francis DM, Barr RM and Greaves MW (1995) Skin mast cell activation by autoantibodies in urticaria and therapeutic implications. in Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. eds. Kitamura Y, Yamamoto S, Galli SJ, Greaves MW. pp 183–192, Raven Press, New York
Hirschmann JV, Lawlor F, English SJC, Lowback JB, Winkelmann RK, Greaves MW (1987) Cholinergic urticaria. Arch Dermatol 123:462–467
Holgate ST Bradding P Sampson AP (1996) Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 98:1–13
Horn MP, Gerster T, Ochensberger B, Derer T, Kricek F, Jouvin MH, Kinet JP, Tschernig T, Vogel M, Stadler BM, Miescher SM (1999) Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 29:1139–1148
Juhlin L, Michaelsson G (1969) Cutaneous reactions to kallikrein, bradykinin and histamine in healthy subjects and in patients with urticaria. Acta Derm Venereol (Stockh) 49:26–36
Kanazawa K, Yaoita H, Tsuda F, Okamoto H. (1996) Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 35:195–198
Kaplan AP, et al. 2008 Treatment of chronic autoimmune urticaria with Omalizumab. J Allergy Clin Immnol; 122:569–573
Keahey TM, Greaves MW (1980) Cold urticaria: dissociation of cold-evoked histamine release and urticaria following cold challenge. Arch Dermatol 116:174–177
Kermani F, Niimi N, Francis DM, Barr RM, Black AK, Greaves MW (1995) Characterisation of a novel mast cell-specific histamine-releasing activity in chronic idiopathic urticaria. J Invest Dermatol 105:452
Kikuchi Y, Kaplan AP (2001) Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 107:1056–1062
Kikuchi Y, Kaplan AP (2002) A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109:114–118
Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE (2009) EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 64:1256–1268
Koro O, Dover JS, Francis DM, Black AK, Kelly RW, Barr RM, Greaves MW (1986) Release of prostaglandin D2 and histamine in a case of localised heat urticaria, and effect of treatment. Br J Dermatol 115:721–728
Lawlor F, Black AK, Milford Ward A, Morris R, Greaves MW (1989a) Delayed pressure urticaria: objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol 120:403–408
Lawlor F, Black AK, Breathnach AS, Greaves MW (1989b) Vibratory angioedema: lesion induction, clinical features, ultrastructural findings and response to therapy. Br J Dermatol 120:93–99
Lawrence CM, Jorizzo JL, Black AK, Coutts A, Greaves MW (1981) Cholinergic urticaria associated with angioedema. Br J Dermatol 105:543–550
Leznoff A, Josse RG, Denburg J, Dolovich J (1983) Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119:636–640
Leznoff A, Sussman GL (1989) Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity — a study of 90 patients. J Allergy Clin Immunol 84:66–71
Lowman MA, Rees PH, Benyon RC (1988) Human mast cell heterogeneity. Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils and colon in response to IgE-dependent and non-immunological stimuli. J Allergy Clin Immunol 81:590–597
MacGlashan DW, Bochner BS, Adelman DC (1987) Down regulation of FcεRI expression on human basophils during in vivo treatment of atopic human patients with anti-IgE antibody. J Immunol 158:1438–1445
Magerl M, Pisarevskaja D, Scheufele R, Zuberbier T, Maurer M (2010) Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial Allergy 65:78–83
May CD (1985) Are confusion and controversy about food hypersensitivity really necessary? J Allergy Clin Immunol 75:329–333
Misch K, Black AK, Greaves MW (1983) Almosauri T, Stanworth DR, Passive transfer of cold urticaria to monkeys. Acta Derm Venereol (Stockh) 63:163–164
Morioke S, Takahagi S, Iwamoto K, Shindo H, Mihara S, Kameyoshi Y, Hide M (2010) Pressure challenge test and histopathological inspections for 17 Japanese cases with clinically diagnosed delayed pressure urticaria. Arch Dermatol Res [Epub ahead of print]
Murphy GM, Black AK, Greaves MW (1983) Persisting cholinergic erythema — a variant of cholinergic urticaria. Br J Dermatol 109:343–348
Murphy GM, Zollman PE, Greaves MW, Winkelmann RK (1987) Symptomatic dermographism (factitious urticaria) — passive transfer experiments from human to monkey. Br J Dermatol 116:801–804
Niimi N, Francis DM, Kermani F, Black AK, Barr RM, Grattan CEH, Greaves MW (1996) Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106:1001–1006
O’Donnell BF, Black AK (1995) Urticarial vasculitis. Int Angiol 14:166–174
O’Donell BF, Lawlor F, Simpson J, Morgan M, Greaves MW (1997) The impact of chronic urticaria on quality of life. Br J Dermatol 136:197–201
O’Donnell BF, Barr RM, Black AK, Francis DM, Greaves MW (1998) Intravenous immunoglobulin in chronic autoimmune urticaria. Br J Dermatol 138:101–106
O’Donnell BF, O’Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, Greaves MW, Welsh K (1999) Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 140:853–858
Ohnishi-Inoue Y, Mitsuya K, Horio T (1998) Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist. Br J Dermatol 138:483–485
Ozkaya-Bayazit E, Demir K, Ozgaroglu E, Kaymakoglu S, Ozamagar G (1998) Helicobacter pylori eradication in patients with chronic urticaria. Arch Dermatol 314:1165–1166
Pachlopnik JM, Horn MP, Fux M, Dahinden M, Mandallaz M, Schneeberger D, Baldi L, Vogel M, Stadler BM, Miescher SM (2004) Natural anti-FcεRIα autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 22:43–51
Pachor ML, Lunardi C, Nicolis F, Cortina P, Accordini C, Marchl G, Corrocher R, de Sandre G (1987) Utilita del propranololo nel trattamento dell’orticaria colinergica. Clin Ter 120:205–210
Pacor ML, Di Lorenzo G, Corrocher R. (2001) Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 31:1607–1614
Pandey V, Mihara S, Fensome-Green A, Bolsover S, Cockcroft S (2004) Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol 172:4048–4058
Pastorello EA (1995) Evaluating new tests for the diagnosis of food allergy. Allergy 50:289–291
Pirisi A (2000) Antihistamines impair driving as much as alcohol. Lancet 355:905
Ramsay CA (1977) Solar urticaria treatment by inducing tolerance to artificial radiation and natural light. Arch Dermatol 113:1222–1225
Reimers A, Pichler C, Helbling A, Pichler WJ, Yawalkar N (2002) Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 32:1763–1768
Rivera J (2002) Molecular adapters in FceRI signaling and the allergic response. Curr Opin Immunol 14:688–693
Rorsman H (1961) Basopenia in urticaria. Acta Allergol 16:185–215
Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW (1998) Anti-FcεRI autoantibodies and basophil histamine release ability in chronic idiopathic urticaria. J Allergy Clin Immunol 102:651–658
Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW (1999a) Chronic idiopathic urticaria: comparison of clinical features of patients with or without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 40:443–450
Sabroe RA, Poon E, Orchard GE, Lane D, Francis DM, Barr RM, Black AK, Greaves MW (1999b) Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRIα or anti-IgE autoantibodies. J Allergy Clin Immunol 103:484–493
Sabroe RA, Grattan CEH, Francis DM, Black AK, Barr RM, Greaves MW (1999c) The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446–452
Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, Black AK, Stingl G, Greaves MW, Barr RM (2002) Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110:492–499
Schnyder B, Helbling A, Pichler WJ (1999) Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 119:60–63
Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M (2009) High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study J Allergy Clin Immunol. 123:672–679
Sibbald RG, Black AK, Eady RAJ, James M, Greaves MW (1981) Aquagenic Urticaria: evidence of a cholinergic and histaminergic basis. Br J Dermatol 105:297–302
Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, Church DS, Dimitrov V, Church MK (2010) The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria J Allergy Clin Immunol. 125:676–682
Smith CH, Atkinson B, Morris RW, Hayes N, Foreman JC, Lee TH (1992) Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria. Lancet. 339:91–93
Tam SW, Demissie S, Thomas D, Daeron M (2004) A bispecific antibody against human IgE and human FcγRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 59:772–780
Takahagi S, Tanaka T, Ishii K, Suzuki H, Kameyoshi Y, Shindo H, Hide M (2009) Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 160:426–428
Tanaka T, Kameyoshi Y, Hide M (2006) Analysis of the prevalence of subtypes of urticaria and angioedema. Arerugi 55:134–139
Tong LJ, Balakrishnan G, Kochan JP, Kinet J-P, Kaplan AP (1997) Assessment of autoimmunity in chronic urticaria. J Allergy Clin Immunol 99:461–465
Ujiie H, Shimizu T, Natsuga K, Arita K, Tomizawa K, Shimizu H (2006) Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines. Clin Exp Dermatol 31:588–602
Wedi B, Wagner S, Werfil T, Mann MP, Kapp A (1998) Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int Arch Allergy Immunol 116:288–294
Wolfrom E, Chene G, Boisseau H, Beylot C, Geniaux M, Taleb A (1995) Chronic urticaria and Toxocara canis. Lancet 345:196
Wong E, Eftekhari N, Greaves MW, Milford Ward A (1987) Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 116:353–356
Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP (2002) TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 109:694–700
Zweiman B, Valenzano M, Atkins PC, Tanus T, Getsy JA (1996) Characteristics of histamine-releasing activity in sera of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 98:89–98
Zuberbier T, Greaves MW, Juhlin L, Kobza-Black A, Maurer D, Stingl G, Henz BM (2001) Definition, classification, and routine diagnosis of urticaria: a consensus report. J Invest Dermatol Symp Proc. 6:123–127
Zuberbier T, Asero R, Bindslev-Jensen C, Canonica W, Church M K, Gimenez-Arnau A, Grattan CEH, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M (2009) EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64:1417–1426
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2011 Springer-Verlag/Wien
About this chapter
Cite this chapter
Grattan, C., Hide, M., Greaves, M.W. (2011). Chronic Urticaria as an Autoimmune Disease. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/978-3-211-99225-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-211-99225-8_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-99224-1
Online ISBN: 978-3-211-99225-8
eBook Packages: MedicineMedicine (R0)